King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recs

1
Player Avatar oxsigtech (46.24) Submitted: 8/12/2008 9:50:44 AM : Outperform Start Price: $11.27 KG Score: +21.57

They have had some rough times in the past, but these guys sell a lot of generic drugs.

Featured Broker Partners


Advertisement